Are financial incentives holding back cures?
“A promising new cure sparked a wave of renewed interest in gene therapies about a decade ago — but it also set off alarm bells in the financial world.”
High Rates of HCV Reinfection in NYC
“Over nearly two decades, a study conducted in New York City (NYC) has revealed high rates of Hepatitis C virus (HCV) reinfection among men who have sex with men (MSM) and have HIV. Published in Clinical Infectious Diseases, research by Daniel S Fierer, MD, Professor of Medicine (Infectious Diseases) at the Icahn School of Medicine at Mount Sinai underscores that sexual transmission of HCV is far from uncommon or inefficient in this population. Despite the availability of direct-acting antiviral treatments, the study found these alone are insufficient to eliminate HCV among MSM in NYC.”
Hepatitis C decreasing in Alaska
“FAIRBANKS, Alaska (KTVF) – Alaska has historically experienced relatively high rates of blood-borne illnesses such as Hepatitis C. In recent years, this disease has shown a sudden downward trend.”
How a Cure for Hepatitis C Changed the Face of Liver Transplantation
“One reason behind the rise in the availability of livers for transplant over the past 10 years may be surprising: Food and Drug Administration (FDA) approval of drugs to effectively treat hepatitis C.”
World Hepatitis Day: PAHO calls for expanded access to diagnosis and treatment
“Washington, DC, July 25, 2024 (PAHO) – In the run up to World Hepatitis Day (July 28), the Pan American Health Organization (PAHO) is urging countries to expand access to testing and treatment for viral hepatitis, which affects more than ten million people in the Americas, only 23% of whom are diagnosed.”
Hospital Spotlight: ‘Even on my worst day today, it’s still always better than my best day using’
“After struggling for years with a drug addiction and its health effects, Jesse Morden is giving back by serving at the Niagara Health hepatitis C clinic as a peer support worker.”
Treating viral hepatitis: Therapeutic lessons for future pandemics
“300 million people live with viral hepatitis globally. Through medical research innovation, therapeutics have been developed to treat the various strains of the disease and prevent progression to liver cancer. Ahead of this year’s World Hepatitis Day on 28 July, we explore how learnings from the therapeutic response to viral hepatitis can be applied to pathogens of pandemic potential.”
CDC Joins the World in Recognizing World Hepatitis Day
CDC is working to eliminate viral hepatitis in the United States and around the world. CDC collaborates with international partners to help countries experiencing high rates of infection to prevent, control, and eliminate viral hepatitis.
